Accordingly, CSF NfL levels in relapsing MS were 3-fold higher than in healthy controls (951.8 vs. 284.4 pg/ml) and associated with relapse and cortical lesions (Damasceno et al., 2019). This evidence concerns the gene NEFL and myeloid sarcoma.